Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India (Q60951055)

7

object named as

Kailapuri G Murugavel

0 references

author name string

K K Vidyavijayan

1

0 references

Narayanaiah Cheedarala

2

0 references

Hemalatha Babu

3

0 references

Lucia K Precilla

4

0 references

Pattabiraman Sathyamurthi

5

0 references

Padmapriyadarsini Chandrasekaran

6

0 references

Srikanth P Tripathy

9

0 references

Luke Elizabeth Hanna

Creative Commons Attribution 4.0 International

10

0 references

language of work or name

English

0 references

publication date

2018

0 references

published in

Frontiers in Immunology

0 references

volume

9

0 references

page(s)

2841

0 references

copyright license

start time

17 December 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The epidemiology of HIV in India

1 reference

12 December 2020

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

12 December 2020

Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mang

1 reference

12 December 2020

The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner

1 reference

12 December 2020

Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants

1 reference

12 December 2020

GP120: target for neutralizing HIV-1 antibodies

1 reference

12 December 2020

Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections

1 reference

12 December 2020

Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays

1 reference

12 December 2020

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

1 reference

12 December 2020

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm

1 reference

12 December 2020

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

12 December 2020

Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables

1 reference

12 December 2020

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

12 December 2020

Broad neutralization coverage of HIV by multiple highly potent antibodies

1 reference

12 December 2020

Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection

1 reference

12 December 2020

Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1

1 reference

12 December 2020

HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes

1 reference

12 December 2020

Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design

1 reference

12 December 2020

The development of CD4 binding site antibodies during HIV-1 infection

1 reference

12 December 2020

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

1 reference

12 December 2020

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

1 reference

12 December 2020

Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

1 reference

12 December 2020

Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis

1 reference

12 December 2020

A global approach to HIV-1 vaccine development

1 reference

12 December 2020

A critical question for HIV vaccine development: which antibodies to induce?

1 reference

12 December 2020

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface

1 reference

12 December 2020

Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

1 reference

12 December 2020

Antigenicity and immunogenicity of a trimeric envelope protein from an Indian clade C HIV-1 isolate

1 reference

12 December 2020

HIV broadly neutralizing antibody targets

1 reference

12 December 2020

Antibody responses to envelope glycoproteins in HIV-1 infection

1 reference

12 December 2020

HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers

1 reference

12 December 2020

Immune correlates of vaccine protection against HIV-1 acquisition

1 reference

12 December 2020

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design

1 reference

12 December 2020

Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections

1 reference

12 December 2020